Evidence map›Paper›PMID 33471170›Full record

ArticleEuropean archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery2021

Objective gustatory and olfactory dysfunction in COVID-19 patients: a prospective cross-sectional study.

Thirza Singer-Cornelius, Julian Cornelius, Michael Oberle, Frank U Metternich, Steffi Johanna Brockmeier

Open access · bronzeAbstract read
In one paragraph

Article in European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 2 pooled it
6.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 2 syntheses or guidelines pooled it, 59 citations in OpenAlex.

  1. Pooled it
  2. Systematic review and meta-analysis of olfactory and gustatory dysfunction in COVID-19.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2022
    Pooled it
  3. Article
  4. Article
  5. Taste dysfunction in Long COVID.bioRxiv : the preprint server for biology · 2025
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Objective Evaluation of Smell and Taste Senses in COVID-19 Patients.Turkish archives of otorhinolaryngology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Thirza Singer-CorneliusKlinik für Hals-Nasen-Ohrenheilkunde, Hals- und Gesichtschirurgie, Kantonsspital Aarau, Aarau, Switzerland. thirza.singer@ksa.ch.ORCID http://orcid.org/0000-0001-7323-2660
Julian CorneliusDepartement Chirurgie, Luzerner Kantonsspital, Lucerne, Switzerland.
Michael OberleInstitut für Labormedizin, Kantonsspital Aarau, Aarau, Switzerland.
Frank U MetternichKlinik für Hals-Nasen-Ohrenheilkunde, Hals- und Gesichtschirurgie, Kantonsspital Aarau, Aarau, Switzerland.
Steffi Johanna BrockmeierKlinik für Hals-Nasen-Ohrenheilkunde, Hals- und Gesichtschirurgie, Kantonsspital Aarau, Aarau, Switzerland.
Kantonsspital Aarau · CHLuzerner Kantonsspital · CH

Funding

Kantonsspital Aarau KSA 1410.000.128
6 · The paper itself

Abstract

purposeTo determine the prevalence of objective gustatory (GD) and olfactory (OD) dysfunction in COVID-19 patients.

methodsThis is a prospective, cross-sectional study of 51 COVID-19 positive patients diagnosed using RT-PCR-based testing. Of these study participants, 41 reported having present GD and OD at the time of enrollment and ten patients were without symptomatic OD and GD. All participants were objectively tested for OD by Brief Smell Identification Test (BSIT) and for GD by Burghart taste strip test, which were mailed to the participants. The subjective presence and severity of COVID-19 symptoms of smell loss, loss of taste, nasal obstruction, rhinorrhea/mucus production, fever, cough and shortness of breath were also assessed.

resultsOf the 41 patients with GD and OD, only 25.6% (10/39; p ≤ 0.0001) objectively presented GD and 39.1% (16/41; p ≤ 0.0001) OD at the time of their subjective dysfunction. Regarding GD, 23.1% (9/39) suffered from total hypogeusia, 2.6% (1/39) from ageusia. A significant loss of sour (33.3% (13/39)) and salty taste (17.9% (7/39)) could be recognized. Only 10.3% (4/39) showed a reduction in sweet and bitter taste. Concerning OD, 9.8% (4/41) showed a deficit relative to younger age in the BSIT and 29.3% (12/41) results abnormal relative to age.

conclusionSubjective and objective findings in GD and OD differ significantly. Most patients suffering from objective dysgeusia present a deficit in sour and salty taste. TRIAL REGISTRATION NUMBER: DRKS00021516; 22/04/2020.

Indexed as

COVID-19Olfaction DisordersCross-Sectional StudiesHumansProspective StudiesSARS-CoV-2SmellTaste DisordersCOVID-19Gustatory dysfunctionOlfactory dysfunctionSmell lossTaste loss

Identifiers

PMID33471170
PMCPMC7816141
OpenAlexW3125096186

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.